Lunai Bioworks (LNAI) Shares Outstanding (2011 - 2026)
Lunai Bioworks (LNAI) posted quarterly Shares Outstanding (Entity) of $3.1 million for Q1 2026, up 53.91% year-over-year from $2.0 million in Q1 2025, and up 3.34% quarter-over-quarter from $3.0 million in Q4 2025.
Lunai Bioworks (LNAI) Shares Outstanding (2011 - 2026) Analysis & Trends
Lunai Bioworks' Shares Outstanding (Entity) history runs 16 years deep, the most recent figure standing at $3.1 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 53.91% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (up 53.91% YoY), while the FY2025 annual figure was $2.2 million, up 84.31% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $3.1 million, up from $3.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $3.1 million in Q1 2026, with the low at $659978.0 in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $1.2 million (2024), against an average of $1.5 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) grew 1.51% in 2022, then soared 141.2% in 2024.
- Lunai Bioworks' Shares Outstanding (Entity) stood at $696319.0 in 2022, then advanced by 20.68% to $840301.0 in 2023, then soared by 141.2% to $2.0 million in 2024, then jumped by 49.17% to $3.0 million in 2025, then gained by 3.34% to $3.1 million in 2026.
- Business Quant data shows LNAI's Shares Outstanding (Entity) at $3.1 million in Q1 2026, $3.0 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | 3.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.12 Mn |
| Dec 31, 2025 | 2.94 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 2.06 Mn |
| Mar 31, 2025 | 2.03 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 823,156.00 |
| Sep 30, 2023 | 806,009.00 |
| Jun 30, 2023 | 703,317.00 |
| Mar 31, 2023 | 699,683.00 |
| Dec 31, 2022 | 693,865.00 |
| Sep 30, 2022 | 688,743.00 |
| Jun 30, 2022 | 656,600.00 |
| Mar 31, 2022 | 657,985.00 |
| Dec 31, 2021 | 654,025.00 |
| Sep 30, 2021 | 652,746.00 |
| Jun 30, 2021 | 589,591.00 |